Vaxart to present at Euro Global Summit on Vaccines
Vaxart's Associate Director of Immunology Wendy Peters will give a presentation titled “A Non-Replicating Ad5 Vaccine for the Treatment of HSV-2 Infection.” The Tuesday presentation is about the preclinical data from the company’s HSV-2 therapeutic vaccine.
Vaxart uses its proprietary oral recombinant vaccines platform to make medical innovations. Patients receive Vaxart vaccines through tablets that are convenient and stable at room temperature and can be stored and shipped without the bulky equipment for refrigeration. They decrease the risk of needle-stick injuries, are easy to administer, and decrease the waste of medical resources.
The event is being hosted in Birmingham, U.K., at the Hilton Birmingham Metropole Hotel National Exhibition Centre.